Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Banking Stem Cells - FDA Moves to Approve Gene Altering Treatment for Leukemia

Posted by devin@stemsave.com on Jul 13, 2017 4:45:00 PM

The FDA panel’s unanimous recommendation to approve an autologous leukemia treatment represents a paradigm shift in medicine in which gene therapies and stem cells will play leading roles. 

The treatment involves altering the genes of T cells, which are highly specialized stem cells obtained from bone marrow, to target a specific protein on the surface of defective immune cells that cause leukemia. It works by harvesting the cells from the patient, engineering them to target the protein CD-19 on the surface of B Cells, and intravenously administering the cells back into the patient, where they multiply and essentially eradicate the B Cells. Showing promise, over 80% of the patients in the trial have gone into remission.

Read More

Topics: leukemia, gene therapy, regenerative medicine, autologous stem cells

Why We Do What We Do.

Posted by artgreco@stemsave.com on Feb 2, 2016 2:20:11 PM

A recent article in the NY Times served to highlight the progress the medical community is making in combating genetic disorders.

The development of Crispr-Cas9 gene editing technology is profoundly altering the way the medical community is approaching the treatment of genetic disorders.  By enhancing accuracy and simplifying the process for the removal and insertion of specific genes in the DNA sequence, Crispr-Cas9 has brought gene therapy back to the forefront of research in the treatment of genetic disorders.To no surprise, one of the key components of this treatment approach are stem cells.

Read More

Topics: stemsaveblog, gene therapy, CRISPR, Genetic Diseases, genetics, DNA, stem cells

Bubble Boy Gene Therapy Utilizes Stem Cells

Posted by taylor@stemsave.com on Jan 8, 2016 1:31:00 PM

Scientists from the National Institute of Allergy and Infectious Diseases have developed a gene therapy utilizing stem cells, which restores immunity to patients with SCID-X1, also referred to as “Bubble Boy” disease. This genetic disorder prevents immune cells from developing properly, leaving patients prone to potentially fatal infections.

Read More

Topics: stemsaveblog, genetic disease, gene therapy, hematopoietic stem cells, autoimmune disease, transplant, regenerative medicine

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all